| P2093 | author name string | Bing Hu | |
| | Aurelia Meloni-Ehrig | |
| | Robert Barnes | |
| | Nancy Lammert | |
| | Nassim El Hajj | |
| | Scott Sittler | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism | Q24303317 |
| | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 |
| | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 |
| | HER2 testing in gastric cancer: a practical approach | Q28256814 |
| | Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy | Q28272285 |
| | Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989 | Q28346792 |
| | Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients | Q28474358 |
| | The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification | Q29618627 |
| | Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 |
| | Familial gastric cancer: overview and guidelines for management | Q30443024 |
| | Origin of microsatellite instability in gastric cancer | Q30444930 |
| | An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. | Q33682930 |
| | Genetic screening for familial gastric cancer | Q33732282 |
| | Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas | Q34104224 |
| | Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity | Q34216563 |
| | Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research | Q34346468 |
| | Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction | Q34503623 |
| | Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. | Q34554455 |
| | Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial | Q34627996 |
| | Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. | Q34732921 |
| | Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism | Q34740396 |
| | Classification of adenocarcinoma of the oesophagogastric junction | Q34755030 |
| | Translational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not? | Q35196724 |
| | The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes | Q35753518 |
| | Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history | Q35765468 |
| | Early gastric cancer in Europe | Q35840962 |
| | International variation | Q35868021 |
| | Molecular pathobiology of gastric cancer | Q36716762 |
| | Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. | Q37097402 |
| | HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target | Q37149210 |
| | Germline CDH1 deletions in hereditary diffuse gastric cancer families | Q37154264 |
| | Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors | Q37259751 |
| | Gastric pseudo-signet ring cells: a potential diagnostic pitfall | Q37916353 |
| | Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression | Q38300283 |
| | Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer | Q38425012 |
| | Histology of the gastroesophageal junction: an autopsy study | Q41724727 |
| | Germline E-cadherin mutations in familial lobular breast cancer | Q42566631 |
| | Genetic Polymorphisms Associated with 5-Fluorouracil-Induced Neurotoxicity | Q42935990 |
| | Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil | Q43625184 |
| | Detection of beta-ureidopropionase deficiency with HPLC-electrospray tandem mass spectrometry and confirmation of the defect at the enzyme level | Q43862166 |
| | Changing patterns in the incidence of esophageal and gastric carcinoma in the United States | Q43873434 |
| | Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival | Q44513305 |
| | Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo | Q44708292 |
| | Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test | Q44854701 |
| | Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families | Q45243999 |
| | Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations | Q45742163 |
| | Lymphoepithelioma-like carcinoma of the stomach: a subset of gastric carcinoma with distinct clinicopathological features and high prevalence of Epstein-Barr virus infection. | Q45748875 |
| | Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32. | Q46458791 |
| | Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group | Q46733975 |
| | Predicting fluorouracil toxicity: can we finally do it? | Q46733980 |
| | Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor | Q48369441 |
| | Characteristics of gastric cancer invading to the proper muscle layer--with special reference to mortality and cause of death. | Q50561942 |
| | Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System | Q51541559 |
| | Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. | Q51775592 |
| | Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. | Q51778849 |
| | HER-2 amplification is highly homogenous in gastric cancer. | Q51779078 |
| | Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases. | Q53463416 |
| | Dihydropyrimidine dehydrogenase: its role in 5-fluorouracil clinical toxicity and tumor resistance. | Q54073990 |
| | Role of copper accumulation in spontaneous renal carcinogenesis in Long-Evans Cinnamon rats. | Q55024491 |
| | Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred | Q57567850 |
| | Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family | Q58966310 |
| | Rising incidence of adenocarcinoma of the esophagus and gastric cardia | Q68199481 |
| | Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer | Q68290745 |
| | The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity | Q70141373 |
| | Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes | Q71733947 |
| | The gastric cardia in Helicobacter pylori infection | Q72195767 |
| | A genome-wide study of microsatellite instability in advanced gastric carcinoma | Q74157027 |
| | The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002 | Q79339743 |
| | Gastric carcinoma with invasive micropapillary pattern and its association with lymph node metastasis | Q82995147 |
| | Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer | Q83882655 |
| P433 | issue | 3 | |
| P921 | main subject | pathology | Q7208 |
| P304 | page(s) | 251-261 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Journal of gastrointestinal oncology | Q26842467 |
| P1476 | title | Gastric cancer: Classification, histology and application of molecular pathology | |
| P478 | volume | 3 | |